18FDG-PET and large vessel vasculitis: Preliminary data on 25 patients;18FDG-PET e vasculiti dei grandi vasi: Studio preliminare su 25 pazienti

Reumatismo

Volumn 60, Issue 3, 2008, Pages 212-216

  Bruschi, Marco ^a   De Leonardis, F ^a   Govoni, M ^a   Roncali, M ^b   Prandini, N ^b   La Corte, R ^a   Feggi, L ^b   Trotta, F ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

18FDG PET; Giant cell arteritis; Large vessel vasculitis; Takayasu arteritis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; STEROID; ANTIINFLAMMATORY AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LABORATORY TEST; LARGE VESSEL VASCULITIS; MALE; POSITRON EMISSION TOMOGRAPHY; SYMPTOM; VASCULITIS; AORTA ARCH SYNDROME; BLOOD; EVALUATION; GIANT CELL ARTERITIS; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TAKAYASU ARTERITIS; VASCULITIS;

EID: 57149132850     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Montelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003; 30: 1305-13.
2. Webb M, Chambers A, AL-Nahhas A, mason JC, Maudlin L, Rahman L, Frank J. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004; 31: 627-34.
3. Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early takayasu aortitis. Eur Radiol 2003; 13: 400-5.
4. 18F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 30: 730-6.
5. 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674-81.
6. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Athritis Rheum 2006; 55: 131-7.
7. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-34.
8. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
9. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 152: 21-2.
10. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-71.
11. Gonzalez-Gay MA, GarciaPorrua C, Llorca J, Gonzalez-Louazo C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001; 30: 249-56.
12. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246-9.
13. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999; 38: 444-7.
14. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS. Takayasu arteritis. Iann Intern Med 1994; 120: 919-29.
15. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 1999; 23: 16-18.